Guohai Su
Overview
Explore the profile of Guohai Su including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
492
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo J, Li Y, Ma K, Su G
Front Cell Neurosci
. 2025 Mar;
19:1546848.
PMID: 40051676
Background: Autophagy, a regulator of inflammation, has been implicated in various central nervous system pathologies. Despite this, the role and mechanisms of autophagy in lipopolysaccharide (LPS)-induced neuroinflammation are not clear....
2.
Liu Y, Zhang X, Yu L, Cao L, Zhang J, Li Q, et al.
Nat Commun
. 2025 Mar;
16(1):2185.
PMID: 40038329
Macrophage-derived foam cell formation is the hallmark of atherosclerotic plaques prominently attributed to excessive lipid uptake and metabolic disorders. As a classic membrane-localized ubiquitin ligase, the role of RNF128 in...
3.
Yang J, Zhang R, Han B, Li H, Wang J, Xiao Y, et al.
Glob Heart
. 2025 Feb;
20(1):14.
PMID: 39991591
Aim: To evaluate the achievement of metabolic risk factor targets and influencing factors in ACS patients with diabetes during the 12 months after discharge. Methods: We retrospectively analyzed data from...
4.
Lin W, Wang S, Liu R, Zhang D, Zhang J, Qi X, et al.
Mol Med Rep
. 2025 Feb;
31(4).
PMID: 39981923
Cytoplasmic phospholipase A2 (cPLA2) is a vital member of the PLA2 family. Studies have demonstrated that cPLA2 plays a key role in various inflammatory‑related diseases and cancers. However, limited research...
5.
Sun Y, Lv Q, Guo Y, Wang Z, Huang R, Gao X, et al.
J Am Coll Cardiol
. 2024 Nov;
84(20):2037-2047.
PMID: 39505412
Background: Currently available antiproprotein convertase subtilisin/kexin type 9 monoclonal antibodies can effectively decrease low-density lipoprotein cholesterol (LDL-C) levels, but require frequent dosing. Recaticimab is a novel humanized monoclonal antibody against...
6.
Xue Z, Li W, Ding H, Pei F, Zhang J, Gong Y, et al.
PLoS One
. 2024 Sep;
19(9):e0309844.
PMID: 39250512
Background: Helicobacter pylori (H. pylori) virulence factors, particularly the cagA and vacA genotypes, play important roles in the pathogenic process of gastrointestinal disease. Methods: The cagA and vacA genotypes of...
7.
Zhang F, Liu Y, Li Y, Liu X, Zhang Y, Su G
J Genet Genomics
. 2024 Aug;
51(12):1509-1512.
PMID: 39214452
No abstract available.
8.
Yang J, Zhang R, Han B, Li H, Wang J, Xiao Y, et al.
Lipids Health Dis
. 2024 Aug;
23(1):271.
PMID: 39198852
Background: Adverse atherogenic lipid profile is associated with an increased risk of major adverse cardiac events in patients after acute coronary syndrome (ACS). Knowledge regarding the impact of statins on...
9.
Liu P, Wang S, Li K, Yang Y, Man Y, Du F, et al.
Mol Med Rep
. 2024 Jul;
30(3).
PMID: 38994773
Subsequently to the publication of the above article, the authors have realized that, in Fig. 1A, the incorrect image was uploaded to show the ultrastructure of exos isolated from plasma...
10.
Wang X, Qiu M, Cheng Z, Ji X, Chen J, Zhu H, et al.
J Am Heart Assoc
. 2024 May;
13(11):e033669.
PMID: 38818934
Background: A phase 3 trial was conducted to evaluate the efficacy and safety of ongericimab, a monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9, as an add-on treatment to...